Filing Details
ABBOTT LABORATORIES (NYSE:ABT) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event.
8k filedNYSE:ABT
ABBOTT LABORATORIES (ABT) Reports Material Event to SEC
Filing Details ABBOTT LABORATORIES (NYSE:ABT) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event. Market Context ABBOTT…
Market Context
ABBOTT LABORATORIES's stock currently trades at $98.82 with a market capitalization of $202.5B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for ABBOTT LABORATORIES's stock.
All SEC filings for ABBOTT LABORATORIES are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ABT Stock Page
Frequently Asked Questions
Where can I read ABT's SEC filings?
Browse all filings on our ABT SEC filings page.
What types of SEC filings does ABBOTT LABORATORIES file?
Public companies like ABBOTT LABORATORIES file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.